Escalier Biosciences Scores $19 Million in Funding Supporting Therapies for Psoriasis and Other Autoimmune Diseases

Escalier Biosciences and its dermatologic and autoimmune targets received a $19 million series B round funding from European Venture Capital firms Forbion, New Science Ventures and BioGeneration. 

“Escalier’s team has an impressive track record of developing novel compounds targeting diseases with significant unmet medical need,” stated Marco Boorsma, general partner at Forbion who will join Escalier’s board for financing. “We are excited to participate in this financing with New Science Ventures and BioGeneration Ventures and in supporting Escalier’s efforts to develop best-in-class drugs for the treatment of psoriasis and other autoimmune diseases.” 

The nuclear hormone receptor RORγt has emerged as the master regulator of Th17 cell differentiation and the production of pro-inflammatory cytokines. The funding will be used to create small molecule inhibitors of RORγt to lower the production of IL-17 in immune cells. Escalier is also developing both topical and oral RORγt drug candidates for psoriasis, and looks to begin clinicals with its topical compound in 2018.[1] 

“RORγt is a validated target for psoriasis and other autoimmune disorders and our drug candidates have the potential to provide the desired efficacy and safety in psoriasis patients that is currently unavailable with other topical or oral drugs,” said Raju Mohan, Ph.D., Chief Executive Officer of Escalier. “We are incredibly fortunate to have such a supportive syndicate of investors that share our passion in developing novel therapies for challenging targets such as RORγt.”

[1]https://www.prnewswire.com/news-releases/escalier-biosciences-raises-19-million-to-develop-its-topical-and-systemic-rort-therapies-for-psoriasis-and-other-autoimmune-diseases-300613033.html

Follow us on social media for the latest updates in B2B!

Image

Latest

Ace Gardner and Jacob Lewis discuss NIL Deals and Transfer Portals
NIL Deals and Transfer Portals are Also Impacting College Staff and Their Roles
May 23, 2024

College sports is undergoing a significant transformation with the advent of Name, Image, and Likeness (NIL) rights and the increasing prevalence of transfer portals. These changes are reshaping how college staff operate, presenting both opportunities and challenges. With the rise of NIL deals and transfer portals, understanding the behind-the-scenes impact on college coaching staff…

Read More
sales process automation
The Future of Business Success Lies in Real-Time Feedback and Sales Process Automation
May 22, 2024

Amid the rapid pace of technological advancements, sales processes are undergoing significant changes. Companies are increasingly pressured to enhance efficiency, accuracy, and customer satisfaction. According to Forrester’s 2023 report, a staggering 90% of global business buyers experienced stalled purchasing processes due to economic headwinds, emphasizing the importance of price transparency and the need for…

Read More
thaly palanisamy as new president
Stenograph, LLC Announces Thaly Palanisamy as New President
May 22, 2024

Stenograph, LLC is pleased to announce Thaly Palanisamy as president. In his role, Mr. Palanisamy will guide Stenograph in executing its strategic vision: Empowering the capture, preservation, and accessibility of verbatim records. “Thaly’s leadership skills, combined with the Stenograph strategy deployed by our talented team, will ensure success as we charter our course for the…

Read More
rightnow media
Excellence Culture – Brian Mosley
May 22, 2024

“I like your word excellence better than greatness, because you don’t have to sacrifice everything in order to be excellent” – Brian Mosley Those were the words of Brian Mosley (President of RightNow Media) as we discussed the balance of family and leading an organization that is impacting people all over the world. If you…

Read More